摘要
随着分子生物学、免疫学以及相关学科的发展,基因治疗可望成为治疗恶性肿瘤的重要方法,目前基因治疗应用于卵巢癌的临床前实验研究已取得较大进展,给卵巢癌特别是晚期患者的治疗带来新的希望。卵巢癌基因治疗的方法主要有基因增补法、基因矫正法、抗血管形成基因治疗、RNA干扰基因治疗等。现综述近几年卵巢癌基因治疗的研究进展。
出处
《国外医学（妇产科学分册）》
2006年第4期259-263,共5页
Foreign Medical Sciences(Obstet Gynecol Fascicle)
参考文献20
-
1Jamal A,Tiwari RC,Murray T,et al.Cancer statistics,2004.CA Cancer J Clin,2004,54(1):8-29 被引量：1
-
2Caracciolo G,Pozzi D,Caminiti R,et al.Structural characterization of a new lipid/DNA complex showing a selective transfection efficiency in ovarian cancer cells.Eur Phys J E Soft Matter,2003,10(4):331-336 被引量：1
-
3Tanaka M,Inase N,Miyake S,et al.Neuron specific enolase promoter for suicide gene therapy in small lung carcinoma.Anticancer Res,2001,21 (1A):291-294 被引量：1
-
4Ziller C,Lincet H,Muller CD,et al.The cyclin-dependent kinase inhibitor p21 (cip1/waf1) enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells.Cancer Lett,2004,212(1):43-52 被引量：1
-
5Bilsland AE,Anderson CJ,Fletcher-Monaghan AJ,et al.Selective ablation of human cancer ells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.Oncogene,2003,22(3):370-380 被引量：1
-
6Szary J,Kalita K,Przybyszewska M,et al.KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin.Anticancer Res,2001,21(5):3471-3475 被引量：1
-
7Arafat WO,Gomez-Navarro J,Buchsbaum DJ,et al.Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.Gene Ther,2002,9(4):256-262 被引量：1
-
8Cannon MJ,O'Brien TJ,Underwood LJ,et al.Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.Expert Rev Anticancer Ther,2002,2(1):97-105 被引量：1
-
9Madhusudan S,Tamir A,Bates N,et al.A multicenter Phase Ⅰ gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene.Clin Cancer Res,2004,10(9):2986-2996 被引量：1
-
10Fei R,Shaoyang L.Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.Gynecol Oncol,2002,85(1):40-44 被引量：1
同被引文献37
-
1寇伯君,李玉林,张丽红,朱桂彬,王心蕊,李一雷,王悦增,石英爱.可溶性血管内皮生长因子受体2片段的克隆、表达及其在肿瘤血管形成中的作用[J].中华肿瘤杂志,2004,26(6):337-341. 被引量：9
-
2徐伟,陈建利,张佳荣,杨懿霞,万小平.ATP7B基因反义寡核苷酸对卵巢癌SKOV3ipl细胞顺铂敏感性的影响[J].肿瘤,2006,26(1):28-31. 被引量：4
-
3王娟,顾锦法,杨水云,肖田,齐荣,孙兰英,刘新垣.癌特异性双靶向载体的安全性及其携带基因的杀伤性[J].癌症,2006,25(4):385-392. 被引量：10
-
4陈煜,谢小芳.RNAi的作用机制及抗病毒研究进展[J].世界华人消化杂志,2006,14(21):2123-2129. 被引量：11
-
5席勇,邓燕杰.卵巢癌基因治疗研究与进展[J].国外医学（妇产科学分册）,2007,34(3):196-199. 被引量：3
-
6Kramm CM,Niehues T,Rainov NG.Experimental strategies for combined suicide and immune cancer gene therapy[J].Methods Mol Biol,2003,215(6):137-152. 被引量：1
-
7Caracciolo G,Pozzi D,Caminiti R,et al.Structural characterization of a new lipid /DNA complex showing a selective transfection efficiency in ovarian cancer cells[J].Eur Phys J E Soft Matter,2003,10(4):331-336. 被引量：1
-
8Dachs GU,Tupper J,Tozer GM.From bench to bedside for gene directed enzyme prodrug therapy of cancer[J].Anticancer Drugs,2005,16(4):349-359. 被引量：1
-
9Ziller C,Lincet H,Muller CD,et al.The cyclin-dependent kinase inhibitor p21cipl /waf1 enhances the cytotoxicity of gancielovir in HSV-tk transfected ovarian carcinoma cells[J].Cancer Lett,2004,212(1):43-52. 被引量：1
-
10Song Y,Kong B,Ma D,et al.Procaspase-3 enhances the in vitro effect cytosine deam inase-thymidine kinase disuicide gene therapy on human ovarian cancer[J].Int J Gynecol Cancer,2006,16(1):156-164. 被引量：1
二级引证文献2
-
1耿淑征,王晓菲,张玉文,黄河.沙利度胺抗肿瘤作用及其治疗卵巢癌的研究进展[J].实用医药杂志,2014,31(4):365-367. 被引量：1
-
2李志杰,张卓然,韩世愈,史文华,林楠.趋化因子受体CCR3在上皮性卵巢癌中的表达及临床意义[J].现代生物医学进展,2014,14(23):4494-4496.
